AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moretti, D.
Right arrow Articles by Hurrell, R. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moretti, D.
Right arrow Articles by Hurrell, R. F
Agricola
Right arrow Articles by Moretti, D.
Right arrow Articles by Hurrell, R. F
American Journal of Clinical Nutrition, Vol. 83, No. 3, 632-638, March 2006
© 2006 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans 1,2,3

Diego Moretti, Michael B Zimmermann, Rita Wegmüller, Thomas Walczyk, Christophe Zeder and Richard F Hurrell

1 From the Human Nutrition Laboratory, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology, Zürich, Switzerland.

Background: Although ferric pyrophosphate is a promising compound for iron fortification of foods, few data are available on the effect of food matrices, processing, and ascorbic acid on its bioavailability.

Objective: We compared the relative bioavailability (RBV) of ferrous sulfate in an experimental form of micronized dispersible ferric pyrophosphate (MDFP) in a wheat-milk infant cereal given with and without ascorbic acid with the RBV of MDFP from a processed and unprocessed rice meal.

Design: A crossover design was used to measure iron absorption in young women (n = 26) from test meals fortified with isotopically labeled [57Fe]-MDFP and [58Fe]-ferrous sulfate, based on erythrocyte incorporation of stable isotope labels 14 d later.

Results: Geometric mean iron absorption from the wheat-based meal fortified with MDFP was 2.0% and that from the meal fortified with ferrous sulfate was 3.2% (RBV = 62). The addition of ascorbic acid at a molar ratio of 4:1 to iron increased iron absorption from MDFP to 5.8% and that from ferrous sulfate to 14.8% (RBV = 39). In the rice meals, mean iron absorption from MDFP added to the rice at the time of feeding was 1.7%, and that from ferrous sulfate was 11.6% (RBV = 15). The mean iron absorption from MDFP extruded into artificial rice grains was 3.0% and that from ferrous sulfate in unprocessed rice was 12.6% (RBV = 24). Sixteen of 26 subjects were iron deficient. Iron status was a highly significant predictor of the RBV of MDFP (P < 0.001).

Conclusion: RBV of the experimental MDFP varied markedly with food matrix and iron status. Assigning a single RBV value to poorly soluble compounds may be of limited value in evaluating their suitability for food fortification.

Key Words: Iron absorption • ferric pyrophosphate • food processing • ascorbic acid • relative bioavailability • elemental iron • iron stores • food matrix • iron fortification • rice




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. B Zimmermann, B. Troesch, R. Biebinger, I. Egli, C. Zeder, and R. F Hurrell
Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin
Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1280 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Davidsson, S. A. Sarker, K. A. Jamil, S. Sultana, and R. Hurrell
Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children
Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1815 - 1820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Andersson, P. Thankachan, S. Muthayya, R. B Goud, A. V Kurpad, R. F Hurrell, and M. B Zimmermann
Dual fortification of salt with iodine and iron: a randomized, double-blind, controlled trial of micronized ferric pyrophosphate and encapsulated ferrous fumarate in southern India
Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1378 - 1387.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. H. Horl
Clinical Aspects of Iron Use in the Anemia of Kidney Disease
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 382 - 393.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. N. Ames
Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage
PNAS, November 21, 2006; 103(47): 17589 - 17594.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. H. Swain, L. K. Johnson, and J. R. Hunt
An Irradiated Electrolytic Iron Fortificant Is Poorly Absorbed by Humans and Is Less Responsive than FeSO4 to the Enhancing Effect of Ascorbic Acid
J. Nutr., August 1, 2006; 136(8): 2167 - 2174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition